Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis ZOE

Champion - 10+ consecutive years of dividend increases

Max Ratio

10.07

Dividend Yield

1.66 %

5Y Dividend Growth

163.00 %

Consecutive Years

12 years

5Y Average Payout Ratio

32.74 %

Dividend History ZOE

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.66 %
Consecutive Years 12
Forward Annual Dividend 2.00 USD
Consistent Years 12
Dividend CAGR 3Y 20.00 %
Continuous Dividends
Dividend CAGR 5Y 21.37 %
Payout Ratio TTM 32.78 %
Dividend CAGR 10Y 19.62 %
Ex Dividend Date 10/31/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth ZOE

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ZOE

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ZOE

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ZOE

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ZOE

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Zoetis Inc ZOE

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself ZOE

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 20.27
Forward PE 18.90
Enterprise Value Revenue 6.39
Price Sales TTM 5.68
Enterprise Value EBITDA 14.87
Price Book MRQ 10.16

Zoetis Inc Dividends: 1.66 % Yield, History, Payment Schedule

ZOE
Current price
106.36 EUR -0.28 EUR (-0.26%)
Last closed 122.57 USD
ISIN US98978V1035
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Frankfurt Exchange
Capitalization 53 363 724 288 USD
Yield for 12 month -31.10 %
1Y
3Y
5Y
10Y
15Y
ZOE
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+9 256 000 000 USD

Last Year

+8 544 000 000 USD

Current Quarter

+2 400 000 000 USD

Last Quarter

+2 460 000 000 USD

Current Year

+6 396 000 000 USD

Last Year

+5 834 000 000 USD

Current Quarter

+1 717 000 000 USD

Last Quarter

+1 778 000 000 USD
EBITDA 3 991 000 064 USD
Operating Margin TTM 39.33 %
Price to Earnings 20.27
Return On Assets TTM 15.09 %
PEG Ratio 2.34
Return On Equity TTM 49.87 %
Wall Street Target Price 165.36 USD
Revenue TTM 9 397 000 192 USD
Book Value 12.23 USD
Revenue Per Share TTM
Dividend Share 1.93 USD
Quarterly Revenue Growth YOY 0.50 %
Dividend Yield 1.66 %
Gross Profit TTM 6 741 000 192 USD
Earnings per share 5.94 USD
Diluted Eps TTM 5.94 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 8.50 %
Profit Margin 28.21 %

Technical Indicators ZOE

For 52 Weeks

115.25 USD 179.46 USD
50 Day MA 134.95 USD
Shares Short Prior Month 8 734 430
200 Day MA 151.53 USD
Short Ratio 2.04
Shares Short 8 251 796
Short Percent 1.87 %